Literature DB >> 24770407

Longitudinal assessment of endolymphatic hydrops with contrast-enhanced magnetic resonance imaging of the labyrinth.

Claudia Jerin1, Eike Krause, Birgit Ertl-Wagner, Robert Gürkov.   

Abstract

OBJECTIVE: To visualize the progression of endolymphatic hydrops in a patient with Ménière's disease. PATIENT AND METHODS: A 53-year-old patient with definite Ménière's disease underwent locally enhanced inner ear magnetic resonance imaging (LEIM) for visualizing endolymphatic hydrops. Two years later, a second magnetic resonance imaging was performed for follow-up.
RESULTS: The first magnetic resonance image confirmed the presence of endolymphatic hydrops and a treatment with betahistine was begun. Two years later, no more vertigo attacks occurred. The audiometry showed a deterioration of the hearing loss on both sides, whereas the caloric irrigation revealed normal results on both occasions. In comparison to the first examination, the second LEIM showed an augmented endolymphatic hydrops in both the cochlear and the vestibular compartments.
CONCLUSION: For the first time, this case of Ménière's disease shows an enlargement of endolymphatic hydrops in 1 individual in the course of 2 years. A further development of the LEIM technique is desirable to enable the volumetric quantification of endolymphatic hydrops and to monitor the effect of therapies on the course of Ménière's disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770407     DOI: 10.1097/MAO.0000000000000393

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  13 in total

1.  Intratympanic Contrast in the Evaluation of Menière Disease: Understanding the Limits.

Authors:  J Bykowski; J P Harris; M Miller; J Du; M F Mafee
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-26       Impact factor: 3.825

2.  Insufficient image quality.

Authors:  Robert Gürkov; Rita Fernandes Sousa; Jing Zou; Krisztina Barath
Journal:  J Neurol       Date:  2019-05-06       Impact factor: 4.849

3.  Recurrent peripheral vestibulopathy: Is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice?

Authors:  Arnaud Attyé; G Dumas; I Troprès; M Roustit; A Karkas; E Banciu; J Pietras; L Lamalle; S Schmerber; A Krainik
Journal:  Eur Radiol       Date:  2015-03-28       Impact factor: 5.315

Review 4.  Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

Authors:  Rita Sousa; Francisco Raposo; Carla Guerreiro; David Berhanu; Tiago Eça; J Campos; Leonel Luís
Journal:  Neuroradiology       Date:  2021-06-17       Impact factor: 2.804

5.  Transient endolymphatic hydrops after an attack of vestibular migraine: a longitudinal single case study.

Authors:  Valerie Kirsch; S Becker-Bense; A Berman; E Kierig; B Ertl-Wagner; M Dieterich
Journal:  J Neurol       Date:  2018-04-25       Impact factor: 4.849

6.  Morphometric evaluation of facial and vestibulocochlear nerves using magnetic resonance imaging: comparison of Menière's disease ears with normal hearing ears.

Authors:  Annika Henneberger; Birgit Ertl-Wagner; Maximilian Reiser; Robert Gürkov; Wilhelm Flatz
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-05       Impact factor: 2.503

7.  [Hydropic inner ear disease of the vestibular type].

Authors:  V Volgger; E Krause; B Ertl-Wagner; R Gürkov
Journal:  HNO       Date:  2016-09       Impact factor: 1.284

Review 8.  What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.

Authors:  R Gürkov; I Pyykö; J Zou; E Kentala
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

9.  Audiovestibular Function Deficits in Vestibular Schwannoma.

Authors:  Constantin von Kirschbaum; Robert Gürkov
Journal:  Biomed Res Int       Date:  2016-09-22       Impact factor: 3.411

10.  Semi-quantitative vs. volumetric determination of endolymphatic space in Menière's disease using endolymphatic hydrops 3T-HR-MRI after intravenous gadolinium injection.

Authors:  Georg Homann; Volker Vieth; Daniel Weiss; Konstantin Nikolaou; Walter Heindel; Mike Notohamiprodjo; Yvonne Böckenfeld
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.